Click to download REAKSI September 2015, No.25.
- Hydroxyzine: Risk of Effects on Heart Rhythm
- Sodium-Glucose Co-Transporter 2 (SGLT2) Inhibitors: Possible Risk of Diabetic Ketoacidosis
For other issues of REAKSI Drug Safety News, please click here.